177lu-edtmp a potential therapeutic bone agent

Nuclear Medicine Communications

Volumn 19, Issue 6, 1998, Pages 587-592

  Ando, A ^a   Ando, I ^a   Tonami, N ^a   Kinuya, S ^a   Kazuma, K ^a   Kataiwa, A ^a   Nakagawa, M ^a   Fujita, N ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LUTETIUM; LUTETIUM ETHYLENEDIAMINETETRAMETHYLENE PHOSPHONIC ACID; MEDRONATE TECHNETIUM TC 99M; ORGANOMETALLIC COMPOUND; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; ETHYLENEDIAMINE TETRAKIS(METHYLENEPHOSPHONIC ACID); LUTETIUM 177; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BETA RADIATION; BONE; BONE TUMOR; FEMUR; GAMMA RADIATION; HUMAN; MALE; METABOLISM; METASTASIS; PAIN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; RAT; SYNTHESIS; TIME; TISSUE DISTRIBUTION; WISTAR RAT; ACTIMETRY; ANIMAL EXPERIMENT; AUTORADIOGRAPHY; BONE METASTASIS; BONE PAIN; CHELATION; DISSOCIATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MIXTURE; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; URINARY EXCRETION;

ANIMALS; BETA RAYS; BONE AND BONES; BONE NEOPLASMS; FEMUR; GAMMA RAYS; HUMANS; LUTETIUM; MALE; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PAIN; PALLIATIVE CARE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TECHNETIUM TC 99M MEDRONATE; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0031593325     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199806000-00012     Document Type: Article

References (19)

1. Kutzner J, Grimm W, Hahn K. Palliative Strahlentherapie mit Strontium-89 bei ausgedehnter Skellet-metastasierung. Strahlentherapie 1978; 154: 317-322.
2. Mathieu L, Chevalier P, Galy G, Berger M. Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms. Int J Appl Radiat Isot 1979; 30: 725-727.
3. Cheung A, Driedger AA. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate. Radiology 1980; 134: 209-212.
4. Eisenhut M. Preparation of 186Re-perrhenate for nuclear medical purposes. Int J Appl Radiat Isot 1982; 33: 99-102.
5. Eisenhut M. Iodine-131-labeled diphosphonates for the palliative treatment of bone metastases: I. Organ distribution and kinetics of 1-131 BDP3 in rats. J Nucl Med 1984; 25: 1356-1361.
6. Silberstein EB, Williams C. Strontium-89 therapy for the pain of osseous metastases. J Nucl Med 1985; 26: 345-348.
7. Ketring AR. 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals. Nucl Med Biol 1987; 14: 223-232.
8. Goeckeler WF, Edwards B, Volkert WA, Holmes RA, Simon J, Wilson D. Skeletal localization of samarium-153 chelates: Potential therapeutic bone agents. J Nucl Med 1987; 28: 495-504.
9. Appelbaum FR, Sandmaier B, Brown PA et al. Myelosup-pression and mechanism of recovery following administration of 153Sm-EDTMP. Antibody Immunoconj Radiopharm 1988; 1: 263-270.
10. Luo S, Qiao J, Pu M, Deng H. Preliminary investigation of the characteristics of EDTMP chelates with Sm, Tc, Re and In. In: Abstracts of Fourth China-Japan Joint Seminar on Radiopharmaceutical Chemistry, Shanghai, 1997, pp. 50-51.
11. Atkins HL, Mausner LF, Srivastava SC, Meinken GE, Caba-hug CJ, D’Alessandro T. Biodistribution of Sn-117m(4+)-DTPA for palliative therapy of painful osseous métastasés. Radiology 1993; 186: 279-283.
12. Atkins HL, Mausner LF, Srivastava SC, Meinken GE, Caba-hug CJ, D’Alessandro T. Tin-117m(4+)-DTPA for palliation of pain from osseous métastasés: A pilot study. J Nucl Med 1995; 36: 725-729.
13. Sanada S, Ando A, Ando I, Hiraki T, Hisada K. A singletrip mini-paper chromatographic method for rapid purity-control of 99mTc-labeled radiopharmaceuticals. Eur J Nucl Med 1986; 12: 390-393.
14. Ando A, Ando I, Hiraki T, Hisada K. Relation between the location of elements in the periodic table and tumor-uptake rate. Int J Nucl Med Biol 1985; 12: 115-123.
15. Ando A, Ando I, Hiraki T, Hisada K. Relation between the location of elements in the periodic table and various organ-uptake rates. Nucl Med Biol Int J Radiat Appl Instrum 1989; 16: 57-80.
16. Hisada K, Ando A. Radiolanthanides as promising tumor scanning agents. J Nucl Med 1973; 14: 615-617.
17. Ando A, Ando I, Sakamoto K, Hiraki T, Hisada K, Take-shita M. Affinity of 167Tm-citrate for tumor and liver tissue. Eur J Nucl Med 1983; 8: 440-446.
18. Ando A, Ando I. Bone accumulation of 177Lu-EDTMP. In: Abstracts of 17th Annual Meeting of the Pharmaceutical Society of Japan No. 4, Tokyo, 1977, p. 154 (in Japanese).
19. Ando A, Ando I, Tonami N. 177Lu-EDTMP for treatment of painful osseous métastasés. In: Abstracts of the Fourth China-Japan Joint Seminar on Radiopharmaceutical Chemistry, Shanghai, 1997, pp. 52-53.